Product record

Divalproex Sodium: batches declared Not of Standard Quality

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026

9 batches of products named "Divalproex Sodium" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between September 2022 and April 2026. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.

Records by type

9 records linked to Divalproex Sodium in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
9Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2022 to Apr 2026

View original document

Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

9
NSQ batches
5
Manufacturers
Description
Most common reason
Apr 2026
Latest alert

Flagged batches

Batch Manufacturer Reason declared NSQ Tested by Alert
N2407172Mfg 2024-07 · Exp 2026-06 Talent HealthcareUttarakhand The sample does not conform to I.P. for the reason stated under Description.Description CDL, KolkataCDSCO lab Apr 2026
N2407173Mfg 2024-07 · Exp 2026-06 Talent HealthcareUttarakhand The sample does not conform to IP and Manufacturer's specification for the reason stated under Description.Description CDL, KolkataCDSCO lab Mar 2026
N2309085Mfg 2023-09 · Exp 2025-08 Talent Healthcare 66-67Uttarakhand DescriptionDescription CDL, KolkataCDSCO lab Aug 2025
N2309086Mfg 2023-09 · Exp 2025-08 Talent Healthcare 66-67Uttarakhand DescriptionDescription CDL, KolkataCDSCO lab Aug 2025
D2306Mfg 2023-12 · Exp 2026-11 Smith & Kenner Pharmaceuticals Pvt.Ltd NOT OF STANDARD QUALITY 1. The coating is not uniform and rough surface is observed on the whole tablet, hence description does not complies as per IP. 2. The dissolution test parameter doees not complies as per manufacturing method of analysis, hence the drug Divalproex sodium is of Not of Standard Quality with respect to Description and Dissolution test parameter.Dissolution State Lab Drugs Control Laboratory, TelanganaState lab Nov 2024
TMT-0211Mfg 2024-06 · Exp 2026-05 Tas Med (India) Pvt.ltdHimachal Pradesh MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunctin with the official title Divalproex Sodium SR Tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with IP standrds. Hence the drug product shall be deemed to be MISBRANDED DRUG as per Section 17 of the drug and Cosmetics Act 1940 as it not labeled in the prescribed mannerMisbranded State Lab Drugs Control Laboratory, TelanganaState lab Oct 2024
TMT-0164Mfg 2024-06 · Exp 2024-05 Tas Med (India) Pvt.ltdHimachal Pradesh MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunctin with the official title Divalproex Sodium SR Tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with IP standrds. Hence the drug product shall be deemed to be MISBRANDED DRUG as per Section 17 of the drug and Cosmetics Act 1940 as it not labeled in the prescribed mannerMisbranded State Lab Drugs Control Laboratory, TelanganaState lab Oct 2024
TMT-0165Mfg 2024-06 · Exp 2024-05 Tas Med (India) Pvt.ltdHimachal Pradesh MISBRANDED The drug product Divalproex Sodium SR Tablets is official in the currect edition of IP 2022. and as required as per second schedule of the Drugs and cosmetics Act, 1940, the said drug product shall comply with the standards set out in theMisbranded State Lab Drugs Control Laboratory, TelanganaState lab Oct 2024
PF8AO19Mfg 2021-07 · Exp 2023-06 Pure & Cure Healthcare Pvt. LtdUttarakhand Dissolution (Buffer stage)Dissolution CDTL HyderabadCDSCO lab Sep 2022

How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.